Veeral Desai, Chief Strategy & Development Officer at agilon health, inc. (AGL), sold 212,714 shares at $22.50 ($4.8M) on 2022-06-24, disclosed to the SEC on 2022-06-28.
Open-market sale of $4.8M AGL by Chief Strategy & Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.50 | 106,357 | $2.4M | 50.0% |
| 2 | $22.50 | 106,357 | $2.4M | 50.0% |
| Total | $22.50 avg | 212,714 | $4.8M | 100% |
| Filing → |
| AGL | SELL | 2023-03-27 | $4.1M | — | Filing → |
| AGL | SELL | 2023-03-17 | $1.6M | — | Filing → |
| AGL | SELL | 2022-07-25 | $2.2M | — | Filing → |